本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mirum Pharmaceuticals, Inc.

50.80
+0.10000.20%
盤後50.800.00000.00%17:52 EDT
成交量:41.41萬
成交額:2,093.36萬
市值:25.16億
市盈率:-31.54
高:51.07
開:50.70
低:49.91
收:50.70
資料載入中...
2025/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report